We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreThe IPCEI was signed to address the need to equip Europe with a strong, innovative and export-friend...
Read moreAccording to the Department of Health and Social Care (DHSC), the commitments will enable patients t...
Read moreBeyond the regulatory level, a well-recognised challenge for companies launching drugs in orphan dis...
Read moreAccording to the pharmaceutical industry association, Farmaindustria, 40% of orphan drugs approved i...
Read moreIn December 2021, China once again updated its National Reimbursed Drugs List (NRDL).
Read moreIn a statement the ICR said that it welcomes some of the changes, but that it wants to “see furthe...
Read moreThe news comes after the health service negotiated a “significant confidential discount” to the ...
Read moreNICE require a broad range of evidence to be included within the reimbursement dossier, including cl...
Read moreThe changes cover how topics are chosen, the steps and stages in each evaluation and how evidence is...
Read more